TG Therapeutics Investigational Trial Site — Seattle, Washington

TG Therapeutics Investigational Trial Site is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.

TG Therapeutics Investigational Trial Site has participated in 15 clinical trials with 2 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Richter Syndrome, Relapsing Multiple Sclerosis (RMS).

Sponsors: TG Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for TG Therapeutics Investigational Trial Site?

TG Therapeutics Investigational Trial Site has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has TG Therapeutics Investigational Trial Site conducted?

TG Therapeutics Investigational Trial Site has 15 clinical trials on record, with 2 currently active. Their work covers Chronic Lymphocytic Leukemia, Richter Syndrome, Relapsing Multiple Sclerosis (RMS).

Is TG Therapeutics Investigational Trial Site accredited by Crixeo Health?

TG Therapeutics Investigational Trial Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about TG Therapeutics Investigational Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.